Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020.
Viera-Segura O, Vega-Magaña N, García-Chagollán M, Peña-Rodríguez M, Muñoz-Sánchez G, Carranza-Aranda AS, Llamas-Covarrubias IM, Ramos-Solano M, Mora-Mora J, Díaz-Palomera CD, León GE, Zepeda-Nuño JS, Santillán-López E, García-Arellano S, Hernández-Silva CD, Zerpa-Hernandez DA, Muñoz-Rios G, Rodríguez-Sanabria JS, Muñoz-Valle JF. Viera-Segura O, et al. Int J Environ Res Public Health. 2021 Oct 11;18(20):10644. doi: 10.3390/ijerph182010644. Int J Environ Res Public Health. 2021. PMID: 34682388 Free PMC article.
PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population.
Baños-Hernández CJ, Navarro-Zarza JE, Parra-Rojas I, Vázquez-Villamar M, Ramón Padilla-Gutiérrez J, Valle Y, Reyes-Castillo Z, Magdalena Torres-Carrillo N, García-Arellano S, Brennan-Bourdon LM, Muñoz-Valle JF. Baños-Hernández CJ, et al. Hum Immunol. 2017 Sep;78(9):553-558. doi: 10.1016/j.humimm.2017.05.005. Epub 2017 May 25. Hum Immunol. 2017. PMID: 28551357
Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus.
Hernández-Bello J, Palafox-Sanchez CA, García-Arellano S, Reyes-Castillo Z, Pereira-Suárez AL, Parra-Rojas I, Navarro-Zarza JE, De la Cruz-Mosso U, Torres-Carrillo NM, Muñoz-Valle JF. Hernández-Bello J, et al. Arch Med Sci. 2018 Aug;14(5):1025-1032. doi: 10.5114/aoms.2016.62138. Epub 2016 Sep 2. Arch Med Sci. 2018. PMID: 30154884 Free PMC article.
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Hernández-Palma LA, García-Arellano S, Bucala R, Llamas-Covarrubias MA, De la Cruz-Mosso U, Oregon-Romero E, Cerpa-Cruz S, Parra-Rojas I, Plascencia-Hernández A, Muñoz-Valle JF. Hernández-Palma LA, et al. Cytokine. 2019 Mar;115:89-96. doi: 10.1016/j.cyto.2018.11.014. Epub 2018 Nov 19. Cytokine. 2019. PMID: 30467094
Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
García-Arellano S, Hernández-Palma LA, Bucala R, Hernández-Bello J, De la Cruz-Mosso U, García-Iglesias T, Cerpa-Cruz S, Padilla-Gutiérrez JR, Valle Y, Soñanez-Organis JG, Parra-Rojas I, Pereira-Suárez AL, Muñoz-Valle JF. García-Arellano S, et al. Curr Mol Med. 2018;18(10):679-688. doi: 10.2174/1566524019666190129123240. Curr Mol Med. 2018. PMID: 30698113 Clinical Trial.
Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Baños-Hernández CJ, Navarro-Zarza JE, Bucala R, Hernández-Bello J, Parra-Rojas I, Ramírez-Dueñas MG, García-Arellano S, Hernández-Palma LA, Machado-Sulbarán AC, Muñoz-Valle JF. Baños-Hernández CJ, et al. Clin Rheumatol. 2019 Jun;38(6):1643-1654. doi: 10.1007/s10067-019-04459-8. Epub 2019 Feb 12. Clin Rheumatol. 2019. PMID: 30747392
Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.
Reyes-Pérez IV, Sánchez-Hernández PE, Muñoz-Valle JF, Martínez-Bonilla GE, García-Iglesias T, González-Díaz V, García-Arellano S, Cerpa-Cruz S, Polanco-Cruz J, Ramírez-Dueñas MG. Reyes-Pérez IV, et al. Clin Rheumatol. 2019 Nov;38(11):3061-3071. doi: 10.1007/s10067-019-04681-4. Epub 2019 Jul 17. Clin Rheumatol. 2019. PMID: 31312989
29 results